Document
September 14, 2001
ICR 201003-0920-014 · OMB 0920-0600 · Object 16777001.
This document may belong to an older filing. More recent activity for OMB 0920-0600:
Document Viewer [doc]
Document Metadata
| File Type | application/msword |
|---|---|
| File Title | September 14, 2001 |
| Author | phppo user |
| Last Modified By | Writer |
| File Modified | 2009-11-18 |
| File Created | 2026-08-31 |
| Conversion State | complete |
Extracted Text
Month, date, year Centers for Disease Control and Prevention (CDC) Mycobacterium tuberculosis and non-tuberculous mycobacteria Drug Susceptibility Testing Performance Evaluation Program Subject: Preliminary Report for Panel Shipment Year-XX Dear Participant: Attached you will find the preliminary susceptibility testing results for the cultures of M. tuberculosis sent to you in Month year. These preliminary results were determined by the candidate reference laboratories and may not represent the consensus of all participants. Although the Centers for Disease Control and Prevention (CDC) recommends the radiometric method for routine M. tuberculosis drug susceptibility testing, this preliminary report provides the results used in the conventional (agar proportion) method except in the case of pyrazinamide. Participants should use the equivalent radiometric concentrations to determine their results. The participant test results for the NTM culture will be provided in the detailed aggregate report of susceptibility results and methods. This preliminary report will provide you with timely information about the cultures sent to your laboratory. A detailed aggregate report of susceptibility testing results and methods reported by all participants for this panel of four (4) M. tuberculosis isolates and (1) NTM, if applicable, will be emailed before the next scheduled shipment. For additional information or to comment on this report, you may Angela Ragin at 1-888-465-6062 or [email protected] or Sandra Neal at 404 498-2238. We appreciate your support and participation in the M. tuberculosis and NTM Drug Susceptibility Testing Performance Evaluation Program. Sincerely yours, Preliminary Report Susceptibility Testing Results: M. tuberculosis Isolates Panel Shipment 2009-XX STRAIN DRUG RESISTANCE K Isoniazid at 0.2 µg/ml L Fully Susceptible M Pyrazinamide at 100 µg/ml N Streptomycin at 10 µg/ml